When a self-described socialist dismissed GLP-1 drugs as “body fascism,” the comment reignited a heated conversation about medical treatments, social norms and who decides what a healthy body should look like. The debate matters now because appetite-suppressing medications such as GLP-1 receptor agonists have moved from specialist clinics into mainstream headlines, triggering questions about access,…